本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Anaptysbio Inc

26.63
-0.3200-1.19%
盘后26.630.00000.00%18:10 EDT
成交量:42.69万
成交额:1,134.65万
市值:7.82亿
市盈率:-5.56
高:27.22
开:26.93
低:26.12
收:26.95
数据加载中...
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/28

重要事件披露

Form 8-K - Current report
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/02

重要事件披露

Form 8-K - Current report
2023/11/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/10/26

重要事件披露

Form 8-K - Current report
2023/10/10

重要事件披露

Form 8-K - Current report
2023/10/02

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/19

重要事件披露

Form 8-K - Current report
2023/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/06/16

重要事件披露

Form 8-K - Current report
2023/05/11

重要事件披露

8-K - Current report